Search

PROCEPT BioRobotics Corp

Lezárt

SzektorEgészségügy

21.65 -0.73

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

21.35

Maximum

21.9

Fő mutatók

By Trading Economics

Bevétel

-27M

-58M

Értékesítés

11M

94M

Egy részvényre jutó nyereség

-0.47

Profit margin

-61.905

Munkavállalók

888

EBITDA

5.1M

-24M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

+6.84% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

197M

1.2B

Előző nyitás

22.38

Előző zárás

21.65

Hangulat hírek alapján

By Acuity

50%

50%

163 / 340 Rangsor szerint Healthcare

PROCEPT BioRobotics Corp Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 14. 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

2026. aug. 13. 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

2026. aug. 12. 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

2026. aug. 11. 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

2026. aug. 10. 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

2026. aug. 7. 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

2026. aug. 6. 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

2026. aug. 5. 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

2026. aug. 4. 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

2026. aug. 3. 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

2026. júl. 31. 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

2026. júl. 30. 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

2026. júl. 29. 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

2026. júl. 28. 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

2026. júl. 27. 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

2026. júl. 22. 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

2026. júl. 21. 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

2026. júl. 20. 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Társak összehasonlítása

Árváltozás

PROCEPT BioRobotics Corp Előrejelzés

Célár

By TipRanks

6.84% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 23.13 USD  6.84%

Magas 29 USD

Alacsony 19 USD

11 Wall Street elemző 12 hónapos célárain alapulva a(z)PROCEPT BioRobotics Corp termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

11 ratings

3

Vétel

7

Tartás

1

Eladás

Hangulat

By Acuity

163 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat